Vitiligo steals pigment. Up to 100 million people live with the stark, patchy map of an autoimmune reaction. It affects us differently. Some embrace the pattern. Model Winnie Harlow walks runways in it. Others want their skin tone to match up again. The current tools? Flaky at best. None cure the whole condition.
But a small study from Rome suggests a pairing might change the odds. Light therapy. Plus an oral pill.
Giovanni Leone, the lead author, calls vitiligo “a challenging condition to treat.” He’s not wrong. It’s stubborn. His team at Israelite Hospital thinks they found a nudge. A significant one, at least in their data.
What happened in the trial
It’s not exactly a massive global survey. A randomized controlled trial published in Photodermatology, Photoimmunology, & Photomedicine. Just forty patients.
For six months, they stood under an excimer lamp. This device blasts UV light directly at depigmented spots to jumpstart pigment cells. Half the group got something extra. Gliadin-protected superoxide dismut (GP-SOD). An antioxidant supplement taken by mouth.
Six months later. Both groups saw their skin darken. “Significant improvement” is the medical phrase for it.
But the group taking the pill did better.
They saw 51 percent more repigmentation than those using light alone. Their quality of life scores were higher, too. Not just looking better. Feeling it.
Why this combination might work
Let’s pause for reality. The study is tiny. Only twenty people took the combo therapy. The researchers have ties to GliSODin. The company that makes the supplement. Always watch who’s holding the flashlight.
Dermatologists are cautiously intrigued though.
Joshua Zeichner, at Mount Sinai, breaks down the mechanics. Your immune system hates your pigment cells. It attacks them. Inflammation blocks color production. Oxidative stress piles on. It’s chaos at the cellular level.
“Think of the antioxidant as a fire extinguisher,” Zeichner says.
Phototherapy shakes the cells awake. But oxidative stress puts the brakes back on. GliSODin is supposed to dampen that stress. The gliadin coating protects the superoxide dismutase enzyme so it survives the trip through your gut.
Pooja Sodha of George Washington University sees the synergy. “Suppress oxidative stress. Let the light do its work.” It sounds clean. In theory, it makes sense.
The catch and the alternatives
We don’t treat vitiligo because we have to. We do it if the contrast bothers us. There are limits.
Current treatments are capped. Even new JAK inhibitors which block inflammatory signals have rules. You can’t slather them everywhere. No more than 10% of body surface area can be covered, warns dermatologist Cindy Wassef. It’s a constraint for widespread vitiligo.
This oral light combo feels like a wider net.
But who can’t use it?
People with celiac disease. Gluten sensitivity. And those allergic to melons. GliSODin contains melon extracts and gluten components. Check your diet. Check your allergies.
Long-term safety is unknown. No data on how this affects your body’s natural defenses over years. Sodha is clear about this gap. Wassef agrees. We need bigger trials. Larger numbers.
If you’re looking at options right now, the toolbox isn’t empty. Phototherapy still stands. Topical steroids exist. Skin grafts for stable cases. Sunscreen is non-negotiable. Pale burns easily.
Talk to a dermatologist. They’ll map your patches and your risks. The science is shifting. But for now, the map is still yours to read.
